5-氮杂-2'-脱氧胞苷与DNA甲基转移酶抑制剂在髓系白血病和骨髓增生异常综合征治疗中的应用：生物学特性与临床结果。研讨会论文集。意大利罗马，1991年11月3日。 - Suppr | 超能文献

5-Aza-2'-Deoxycytidine and DNA Methyltransferase Inhibitors in the Treatment of Myeloid Leukemias and Myelodysplastic Syndromes: Biological Aspects and Clinical Results. Proceedings of a workshop. Rome, Italy, November 3, 1991.

出版信息

Leukemia. 1993 May;7 Suppl 1:1-60.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

5-Aza-2'-Deoxycytidine and DNA Methyltransferase Inhibitors in the Treatment of Myeloid Leukemias and Myelodysplastic Syndromes: Biological Aspects and Clinical Results. Proceedings of a workshop. Rome, Italy, November 3, 1991.5-氮杂-2'-脱氧胞苷与DNA甲基转移酶抑制剂在髓系白血病和骨髓增生异常综合征治疗中的应用：生物学特性与临床结果。研讨会论文集。意大利罗马，1991年11月3日。

Leukemia. 1993 May;7 Suppl 1:1-60.

2

5-Aza-2'-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present and future trends.5-氮杂-2'-脱氧胞苷（地西他滨）和5-氮杂胞苷在急性髓系白血病和骨髓增生异常综合征治疗中的应用：过去、现在与未来趋势

Leukemia. 1993 May;7 Suppl 1:51-60.

3

DNA methyltransferases as targets for cancer therapy.DNA甲基转移酶作为癌症治疗的靶点。

Drugs Today (Barc). 2007 Jun;43(6):395-422. doi: 10.1358/dot.2007.43.6.1062666.

4

5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly.5-氮杂-2'-脱氧胞苷作为老年急性髓系白血病和骨髓增生异常综合征的分化诱导剂。

Bone Marrow Transplant. 1989 Dec;4 Suppl 3:28-32.

5

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia.在骨髓增生异常综合征和急性髓系白血病中，刺猬信号通路作为可被5-氮杂胞苷靶向的脆弱点。

J Hematol Oncol. 2015 Oct 20;8:114. doi: 10.1186/s13045-015-0211-8.

6

Hypomethylating agents in the treatment of myelodysplastic syndromes and myeloid leukemia.低甲基化剂治疗骨髓增生异常综合征和髓系白血病。

Curr Cancer Drug Targets. 2011 Sep;11(7):837-48. doi: 10.2174/156800911796798940.

7

In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.地西他滨在骨髓增生异常综合征和急性髓系白血病中的体内作用：细胞遗传学和分子研究综述

Ann Hematol. 2005 Dec;84 Suppl 1:32-8. doi: 10.1007/s00277-005-0004-1.

8

Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.5-氮杂-2'-脱氧胞苷对骨髓增生异常综合征患者DNA去甲基化作用的特征分析

Cancer Res. 2005 Aug 15;65(16):7086-90. doi: 10.1158/0008-5472.CAN-05-0695.

9

Use of hypomethylating agents in myelodysplastic syndromes.低甲基化药物在骨髓增生异常综合征中的应用。

Clin Adv Hematol Oncol. 2007 Jul;5(7):544-52.

10

Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase.5-氮杂-2'-脱氧胞苷与安吖啶或1,25-二羟基维生素D3在HL-60髓系白血病细胞及胞苷脱氨酶抑制剂上的相互作用

Leukemia. 1993 May;7 Suppl 1:17-20.

引用本文的文献

1

Decitabine: a historical review of the development of an epigenetic drug.地西他滨：一种表观遗传药物研发的历史回顾

Ann Hematol. 2005 Dec;84 Suppl 1(Suppl 1):3-8. doi: 10.1007/s00277-005-0008-x.